i would like to request all the current data/research data on the off-license drug Low dose naltrexone in new zealand. to include the commonality of prescribing in the south island and best practices to follow when prescribing. Is low dose naltrexone commonly prescribed in new zealand? what is the consent process considered appropriate for doctors to follow when prescribing low dose naltrexone specifically, in general and rural practices in the south island. does a register of prescribers exist. for the years 2018-2020 was low dose naltrexone frequently prescribed and for what reasons.
any chronologically dated statistics of use/prescribing methods/care plans or suggested trial periods/method of administration/reasons for prescribing, relating to the supply of the off-license drug low dose naltrexone in the south island.
defining the protocols associated with prescribing an un-approved medicine namely low dose naltrexone, and the procedures legally required to follow so as not to breach the patient's privacy/health and wellbeing/and to ascertain the appropriate standard of care associated with the prescribing of this drug.
defining 100% if written consent is required for this un-approved drug.
defining 100% the exclusions and inclusions that warrant its prescription, in its unapproved capacity.
define 100% the class of thi8s drug and its commonality of prescribing in the south island by general and rural doctors.
Data does not exist
Tēnā koe Thank you for the request below. Te Tāhū Hauora Health Quality & Safety Commission does not collect data or hold statistics on the commonality of prescribing low dose naltrexone for pain or fibromyalgia and therefore can not respond to this request. Ngā mihi Heidi Cannell
0 Votes
Agency responded
1 Subscriber